In addition to studying VEGF (A and C isoforms were studied separately) and TNF-α, LT-α, IL-6, and IL-10 to refute or validate findings from the pilot cohort, we also analyzed de novo two additional cytokines with putative role in MS, IL-1β, and GM-CSF (33). The gene discussed is CSF2; the disease is myeloid sarcoma.